Type 2 Diabetes Information Center

Some antidiabetic agents may increase pneumonia risk in type 2 diabetes

Some antidiabetic agents may increase pneumonia risk in type 2 diabetes

Compared with current use of metformin + sulfonylurea, the use of thiazolidinediones + metformin was associated with an increased risk of community-acquired pneumonia.

News Insulin pump therapy improves quality of life in adolescents with type 2 diabetes

Insulin pump therapy improves quality of life in adolescents with type 2 diabetes

Adolescents with type 2 diabetes decreased HbA1c levels after using insulin pump therapy for a 3-month period.

News High BMI in late adolescence associated with increased risk of severe liver disease in men

High BMI in late adolescence associated with increased risk of severe liver disease in men

A high BMI is associated with an increased risk for severe liver disease, and the risk is higher in those who also have type 2 diabetes mellitus.

News Insulin initiation in primary care improves HbA1c levels

Insulin initiation in primary care improves HbA1c levels

The Stepping Up model of care produced a clinically and significantly significant improvement in HbA1c among adults with type 2 diabetes managed in primary care.

News Nearly half of all cardiometabolic deaths linked to poor diet

Nearly half of all cardiometabolic deaths linked to poor diet

Suboptimal intake of 10 specific dietary factors is associated with a substantial proportion of deaths due to heart disease, stroke, or type 2 diabetes.

Healthday Metformin, vildagliptin have differing effects on heart rate, blood pressure in diabetes

Metformin, vildagliptin have differing effects on heart rate, blood pressure in diabetes

Vildagliptin lowers blood pressure and elevates heart rate, while metformin increases heart rate with no effect on blood pressure.

Opinion Lifestyle modifications vs pharmacologic treatment for patients with diabetes

Lifestyle modifications vs pharmacologic treatment for patients with diabetes

Applying necessary lifestyle changes as well as incorporating pharmaceutical drugs will improve diabetes in patients compared to drugs alone.

Feature Case Study in Diabetes: Use of DPP-4 inhibitors with GLP-1 agonists

Case Study in Diabetes: Use of DPP-4 inhibitors with GLP-1 agonists

A 63-year-old man with type 2 diabetes was admitted to the hospital to undergo right robotic partial nephrectomy.

Healthday Novel oral glucose lowering drugs reduce adverse events in type 2 diabetes

Novel oral glucose lowering drugs reduce adverse events in type 2 diabetes

Researchers observed a reduced risk of all-cause mortality and CVD with dapagliflozin and a lower risk of mortality with dipeptidyl-peptidase-4 inhibitors.

Opinion A differing opinion on the ACP's new diabetes treatment guidelines

A differing opinion on the ACP's new diabetes treatment guidelines

Pharmacotherapy and combination therapy may be a better alternative to the ACP's diabetes treatment guidelines.

Sign Up for Free e-newsletters